Legislating for the new predictive genetics.

Area of Science:

• Genetics and Law
• Bioethics
• Public Health Policy

Background:

• Advancements in genetic marker technology enable diagnosis, prognosis, and risk prediction for multifactorial diseases like cardiovascular disease and cancer.
• The integration of genetic information into personal and professional life necessitates legal and ethical frameworks.
• Rapid scientific progress and diverse societal norms complicate the regulation of genetic testing.

Purpose of the Study:

• To examine the challenges in regulating the application of new genetic markers across various legal domains.
• To explore potential solutions for creating flexible and responsive regulatory approaches.
• To address the ethical and societal implications of widespread genetic testing.

Main Methods:

• Analysis of legal and ethical issues surrounding genetic marker applications.
• Review of existing regulatory frameworks and their limitations.
• Discussion of potential regulatory strategies, including referenda, moratoria, and ethical codes.

Main Results:

• Regulation of genetic markers is complex due to the pace of discovery and varied public/professional opinions.
• Existing legal fields (family, employment, insurance, property) require specific considerations for genetic information.
• A flexible, context-dependent approach to legislation is crucial.

Conclusions:

• Effective regulation of genetic markers demands a nuanced understanding of scientific, social, and legal factors.
• Solutions must balance innovation with ethical considerations and public trust.
• Developing scientifically accurate and adaptable legislation is key to navigating the challenges of genetic technologies.